Marta Tufet

Last updated

Marta Tufet Bayona
NationalityBritish and Spanish
Other namesMarta Tufet
Education Imperial College London
Occupation(s)Biologist
Public health resource coordinator
Years active2006-present

Marta Tufet Bayona is a British and Spanish biologist and public health resource coordinator with a specialty in malaria. She is executive director of the UK Collaborative on Development Research.

Contents

Early life and education

Tufet is from the United Kingdom. She is half Ecuadorian. [1]

Tufet received a BSc in biology from Imperial College London. [1] She remained there for her doctoral degree, where she specialised in parasitology and studied rhoptry proteins. In 2006, Tufet earned a PhD in cellular and molecular biology from the Faculty of Life Sciences at Imperial College London. Her thesis was titled "Search for Novel Rhoptry Proteins in Plasmodium Berghei". [2]

Career

From 2002 to 2005, Tufet worked as a research assistant at both Imperial College London and Leiden University Medical Center. From 2006 to 2009, Tufet was a scientific copy editor at Nature Publishing.[ citation needed ]

From 2008 to 2009, she was a scientific grants writer at the Charles Darwin Foundation for the Galapagos Islands in Ecuador. [3] It was whilst working at the Charles Darwin Foundation that she first became concerned about the challenges that face scientific researchers in the developing world. She lived in the Galápagos Islands and became involved with the Galapagos Conservation Trust. [1]

From 2009 to 2017, Tufet worked in various positions at Wellcome Trust in London. [4] In her position as science portfolio adviser, she coordinated grant funding in the areas of animal health, bacteriology and immunology. This involved coordination of projects for the KEMRI-Wellcome Trust Research Programme (a partnership with the Kenya Medical Research Institute), the UK Biobank, the Insect Pollinators Initiative and the Bloomsbury Centre for Tropical Medicine. As international activities adviser, she worked to support educational research as part of the African Institutions Initiative. [5] She worked on the Global Health Trials Initiative, DELTAS Africa programme, and on the Ebola Research Funding Initiative. [6] [7]

In 2014, Tufet worked as an adviser in discovery and translational sciences for the Bill & Melinda Gates Foundation in Seattle, where she looked to develop collaborative projects with the Wellcome Trust. As part of this work, from 2014 to 2015, she established the Alliance for Accelerating Excellence in Science in Africa (AESA) partnership, part of the African Academy of Sciences that was endorsed by the African Union, which looks to develop research infrastructure, support entrepreneurs, train young scientists and identify gaps in African science. [8] [9] She spent one year working at the African Academy of Sciences to implement the AESA partnership, which was in coordination with the African Union's economic development program New Partnership for Africa's Development (NEPAD). The work was funded by the Bill & Melinda Gates Foundation, the Wellcome Trust, and Department for International Development (DFID). As part of her work at the Wellcome Trust, Tufet was involved with the Ebola research response. [10] As part of this work, she oversaw the Kenya Medical Research Institute (KEMRI) programme in Nairobi, Kenya.

From 2016 to 2017, Tufet worked the UK Department of Health and Social Care as a global health research advisor, where she led the United Kingdom's first National Institute for Health Research Global Health Research Programme. [11]

Tufet has served on the World Health Organization Scientific Working Group on research capacity strengthening. [12]

In 2018, Tufet became executive director of the UK Collaborative on Development Research (UKCDR), an interdisciplinary group of governmental departments and international development funding providers [13] [14]

Tufet is involved with the global response to the COVID-19 pandemic. [15] As part of this effort, she partnered with The Global Health Network and the African Academy of Sciences to survey researchers and better understand what the community needs. She identified that researchers needed guidance in how to mitigate myths as well as advice on how and when to implement social distancing. [15] [16]

Selected works and publications

Selected works

Selected publications

Related Research Articles

<span class="mw-page-title-main">Wellcome Trust</span> British healthcare research charity established in 1936

The Wellcome Trust is a charitable foundation focused on health research based in London, in the United Kingdom. It was established in 1936 with legacies from the pharmaceutical magnate Henry Wellcome to fund research to improve human and animal health. The aim of the Trust is to "support science to solve the urgent health challenges facing everyone." It had a financial endowment of £29.1 billion in 2020, making it the fourth wealthiest charitable foundation in the world. In 2012, the Wellcome Trust was described by the Financial Times as the United Kingdom's largest provider of non-governmental funding for scientific research, and one of the largest providers in the world. According to their annual report, the Wellcome Trust spent GBP £1.1Bn on charitable activities across their 2019/2020 financial year. According to the OECD, the Wellcome Trust's financing for 2019 development increased by 22% to US$327 million.

<span class="mw-page-title-main">Peter Piot</span> Belgian microbiologist (born 1949)

Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.

<span class="mw-page-title-main">Kilifi</span> Town Council in Kilifi County, Kenya

Kilifi is a town on the coast of Kenya, 56 kilometres (35 mi) northeast by road of Mombasa. The town lies on the Kilifi Creek and sits on the estuary of the Goshi River. Kilifi is capital of the Kilifi County and has a population of 122,899.

The Kenya Medical Research Institute (KEMRI) is a state corporation established through the Science and Technology (Amendment) Act of 1979,, during the tenure of Nicholas Biwott as Minister of State, as the national body responsible for carrying out health research in Kenya.

<span class="mw-page-title-main">Agnes Binagwaho</span> Rwandan pediatrician

Agnes Binagwaho is a Rwandan Politian, pediatrician and co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996, she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a professor of global health delivery practice since 2016 and a professor of pediatrics since 2017 at the University of Global Health Equity. She resides in Kigali.

<span class="mw-page-title-main">Jeremy Farrar</span> British medical researcher

Sir Jeremy James Farrar is a British medical researcher who has served as chief scientist at the World Health Organization since 2023. He was previously the director of the Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.

The Global Health Innovative Technology Fund, headquartered in Japan, is an international public-private partnership between the Government of Japan, 16 pharmaceutical and diagnostics companies, the Bill & Melinda Gates Foundation, the Wellcome Trust and United Nations Development Programme. It funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. Bill Gates has noted that "GHIT draws on the immense innovation capacity of Japan’s pharmaceutical companies, universities and research institutions to accelerate the creation of new vaccines, drugs and diagnostic tools for global health." Margaret Chan, former Director-General of the World Health Organization, said: "The GHIT Fund has stepped in to provide that incentive in a pioneering model of partnership that brings Japanese innovation, investment and leadership to the global fight against infectious disease."

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

The Malaria Eradication Scientific Alliance (MESA) is an organization founded on the research carried out by the Malaria Eradication Research Agenda (malERA). "malERA" was a project carried out by the scientific community to identify the steps and future research that must be done in order to eradicate malaria. It was created after the Malaria Forum in 2007, hosted by the Bill and Melinda Gates Foundation, reestablished malaria eradication as a long-term goal. "malERA" first launched in 2008, and resulted in a research and development agenda which was published in a PLoS Medicine magazine in 2011. MESA was formed in 2012 to continue the goals of malERA through research and development of methods to fight malaria.

Faith Hope Among’in Osier is a Kenyan immunologist, paediatrician and educator.

<span class="mw-page-title-main">Heidi Larson</span> Anthropologist and immunisation expert

Heidi J. Larson, Lady Piot is an American anthropologist and the founding director of the Vaccine Confidence Project. Larson headed Global Immunisation Communication at UNICEF and she is the author of Stuck: How Vaccine Rumors Start and Why They Don't Go Away. She was recognized as one of the BBC's 100 women of 2021.

<span class="mw-page-title-main">Jean-Jacques Muyembe-Tamfum</span> Virologist known for working with Ebola

Jean-Jacques Muyembe is a Congolese microbiologist. He is the general director of the Democratic Republic of the Congo Institut National pour la Recherche Biomedicale (INRB). He was part of team at the Yambuku Catholic Mission Hospital that investigated the first Ebola outbreak, and was part of the effort that discovered Ebola as a new disease, although his exact role is still subject to controversy. In 2016, he led the research that designed, along with other researchers at the INRB and the National Institute of Health Vaccine Research Center in the US, one of the most promising treatment for Ebola, mAb114. The treatment was successfully experimented during recent outbreaks in the DRC, on the express decision of the then DRC Minister of Health, Dr Oly Ilunga, despite a prior negative advice from the World Health Organization.

<span class="mw-page-title-main">Marie-Paule Kieny</span> French virologist and science writer

Marie-Paule Kieny is a French virologist, vaccinologist, public health expert and science writer. She is currently director of research at INSERM and chief of the board at DNDi.

Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource setting, and helped to organise the trial for the drug brincidofovir during the 2014 Ebola virus outbreak.

Azra Catherine Hilary Ghani is a British epidemiologist who is a professor of Infectious Disease Epidemiology at Imperial College London. Her research considers the mathematical modelling of infectious diseases, including malaria, bovine spongiform encephalopathy and coronavirus. She has worked with the World Health Organization on their technical strategy for malaria. She is associate director of the MRC Centre for Global Infectious Disease Analysis.

<span class="mw-page-title-main">Kevin Marsh (researcher)</span> British Malariologist and academic

Kevin Marsh is a British Malariologist, academic and a researcher. He is a Professor of Tropical Medicine and Director of Africa Oxford Initiative at University of Oxford. He is also a senior advisor at African Academy of Sciences.

<span class="mw-page-title-main">Christian Happi</span>

Christian Happi is a Professor of Molecular Biology and Genomics in the Department of Biological Sciences and the Director of the African Centre of Excellence for Genomics of Infectious Diseases, both at Redeemer’s University. He is known for leading the team of scientists that used genomic sequencing to identify a single point of infection from an animal reservoir to a human in the Ebola outbreak in West Africa. His research focus is on infectious diseases, including malaria, Lassa fever, Ebola virus disease, HIV, and SARS-CoV-2.

Sanjeev Krishna,, is a British physician and parasitologist whose research focuses on affordable diagnosis and treatment of diseases such as COVID-19, malaria, Ebola, African trypanosomiasis, leishmaniasis, and colorectal cancer. Krishna is Professor of Medicine and Molecular Parasitology at St George's, University of London and St George's Hospital.

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is an international research initiative based in Oxford, England. It is hosted at the Nuffield Department of Medicine within the University of Oxford and led by the Epidemic diseases Research Group Oxford (ERGO). ISARIC is funded by the Bill & Melinda Gates Foundation, Foreign, Commonwealth and Development Office, and Wellcome Trust.

John Wright FRCP FFPH FRSA is a British specialist in epidemiology, an applied researcher, and a doctor in the National Health Service (NHS). He established the Bradford Institute for Health Research, based at Bradford Royal Infirmary, in 2007, based at the Bradford Teaching Hospitals NHS Foundation Trust.

References

  1. 1 2 3 "Marta Tufet". Galapagos Conservation Trust. 21 August 2014.
  2. ↑ Tufet Bayona, Marta (2006). Search for Novel Rhoptry Proteins in Plasmodium Berghei (PhD). Imperial College London. OCLC   930642746.
  3. ↑ "Speaker Marta Tufet". Women Leaders in Global Health. 2018.
  4. ↑ Stakeholder Meeting: Report on Capacity Development (PDF). Berlin: European & Developing Countries Clinical Trials Partnership. 3 July 2014. pp. 9, 10, 18.
  5. ↑ Tufet, Marta (19 March 2012). African Institutions Initiative: Learning and Evaluation (PDF). London: Measuring Impact of Higher Education for Development Conference, Wellcome Trust.
  6. ↑ Katsnelson, Alla (23 January 2014). "Charities: Profiting from non-profits" (PDF). Nature. 505 (7484): 575–576. doi: 10.1038/NJ7484-575A . PMID   24459710.
  7. ↑ Gallagher, James (24 October 2014). "'Millions of Ebola vaccines' in 2015". BBC News.
  8. ↑ "The Alliance for Accelerating Excellence in Science in Africa (AESA): The AAS. Shifting the centre of gravity for African science to Africa". Alliance for Accelerating Excellence in Science in Africa (AESA). Archived from the original on 17 May 2021. Retrieved 17 July 2020.
  9. ↑ "Dr Marta Tufet, RSTMH Trustee". Royal Society of Tropical Medicine and Hygiene. 2015.
  10. ↑ Robinson, Debbie (15 November 2018). "UK research funding for international development: a changing landscape". University of Exeter.
  11. ↑ "Keynote speakers: Dr Marta Tufet". Building Global Partnerships for Global Challenges, University of Bristol. 2018.
  12. ↑ "Members of the Scientific Working Group on research capacity strengthening". TDR, the Special Programme for Research and Training in Tropical Diseases. World Health Organization (WHO). Retrieved 17 July 2020.
  13. ↑ Tufet, Dr Marta (8 June 2019). "Global issues often seem a world away – but it is in Britain's interest to tackle them". The Telegraph.
  14. ↑ "Marta Tufet, Executive Director". UK Collaborative on Development Research (UKCDR). Retrieved 17 July 2020.
  15. 1 2 Ndlovu, Deborah-Fay (16 July 2020). "Global research community asks for the right research in the right places for COVID-19". American Association for the Advancement of Science (AAAS).
  16. ↑ The African Academy of Sciences; AUDA NEPAD; UK CDR; Marsh, Kevin; Alobo, Moses; Ambali, Aggrey; Muzawazi, Daphine; Tufet, Marta; Norton, Alice; Lang, Trudie (14 July 2020). Update – Research And Development Goals for COVID-19 In Africa: The African Academy of Sciences Priority Setting Exercise (PDF). The African Academy of Sciences.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.